微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 38.39% | 10.01% | 8.21% | 92/133 | 51.33% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 35.48% | -4.42% | 6.71% | 97/133 | 51.45% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 33.25% | -7.13% | -7.33% | 100/133 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 35.88% | -4.2% | 2.81% | 99/133 | 52.13% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 34.9% | -4.43% | -5.98% | 100/133 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 37.12% | -6.65% | 3.68% | 99/133 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 35.81% | -12.68% | -4.4% | 96/133 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 37.46% | 7.5% | 2.56% | 100/133 | 53.09% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 36.52% | 7.07% | -8.17% | 96/133 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 39.77% | 21.95% | -3.02% | 93/133 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 41% | 19.92% | 17.68% | 87/133 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 34.84% | -8.37% | 2.16% | 105/133 | 53.59% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 34.11% | 2% | 4.6% | 99/133 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 32.61% | -9.12% | -4.63% | 107/133 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 34.19% | 2% | -10.08% | 93/133 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 38.03% | -11.59% | 5.98% | 107/133 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 35.88% | -22.68% | -16.58% | 100/133 | 58.42% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 43.01% | 9.01% | -7.31% | 102/133 | 59.59% | 正海生物 | 90.78% | 行业排名> |
| 2020-06-30 | 46.4% | 2% | 17.6% | 85/133 | 59.94% | 正海生物 | 91.59% | 行业排名> |
| 2019-12-31 | 39.46% | 10.88% | 10.88% | 91/133 | 56.37% | 正海生物 | 92.23% | 行业排名> |
| 2018-12-31 | 35.59% | -15.5% | -15.5% | 86/133 | 55.53% | 正海生物 | 92.69% | 行业排名> |
| 2017-12-31 | 42.11% | -4.47% | -4.47% | 70/133 | 55.34% | 正海生物 | 92.61% | 行业排名> |
| 2016-12-31 | 44.09% | 2% | 2% | 52/133 | 56.43% | 正海生物 | 94.38% | 行业排名> |